Race Against Dementia Fellowships
Dementia Researcher
10/19/20
•48m
About
Comments
Featured In
Founded by Formula 1 racing legend Sir Jackie Stewart, Race Against Dementia is a global charity, founded by Sir Jackie Stewart, to fund pioneering research into the prevention and cure of dementia. Adam Smith is in the driving seat, talking with Race Against Dementia CEO, Dr Penny Moyle, and Race Against Dementia Research Fellow, Dr Claire Durrant from The University of Edinburgh. In this week’s show we learn about the charity, its mission, the unique Fellowship programme and provide advise for anyone thinking of applying for the current funding call (deadline 20th January 2021). The Race Against Dementia Fellowship Programme draws from the most promising scientific talent around the world; to catalyse their research work by driving a shift in culture that learns from innovation in high technology engineering research and implementation, such as in Formula 1; and to drive collaboration across disciplines and institutions to help fast-track their progress to become leaders in the field. You can find out more about our panellists, and read a transcript of this podcast on our website: https://www.dementiaresearcher.nihr.ac.uk/podcast-race-against-dementia-fellowships/ _____________________________________________________________________ For more information on Race Against Dementia visit: https://www.raceagainstdementia.com/ For information, and details on how to apply for the Race Against Dementia Fellowship (Deadline 20th January 2021), administered by Alzheimer’s Research UK visit: https://www.alzheimersresearchuk.org/grants/race-dementia-fellowship/ A webinar has been scheduled for 18:00 GMT on the 16th November. This is a a chance for potential applicants to hear from the existing Fellows, receive tips on the application process and to ask questions from the ARUK Team. To register for the webinar visit: https://ucl.zoom.us/webinar/register/9716038273385/WN_tOY98S8LQrGLJg_04E7Snw _____________________________________________________________________ Like what you hear? Please review, like, and share our podcast - and don't forget to subscribe to ensure you never miss an episode. Register on our website to access information on all the latest research funding calls, to find events, blogs and to join our online early career dementia research community. This podcast is brought to you in association with Alzheimer's Research UK and Alzheimer's Society, who we thank for their ongoing support.
Previous Episode
Using Artificial Intelligence & data to fight dementia
October 5, 2020
•55m
Dr Megan O’Hare interviews Professor Bart De Strooper and Professor David Llewellyn, discussing the new UK Dementia Research Institute and DEMON Network partnership to unlock the potential of Artificial Intelligence (AI). Professor Bart De Strooper is National Director and Group Leader at the UK Dementia Research Institute and Group Leader in his own research he looks at the cellular and molecular mechanisms underlying Alzheimer’s disease and other neurodegenerative disorders. Professor David Llewellyn is the DEMON Network Director and an Associate Professor at the University of Exeter Medical School and a Fellow at the Alan Turing Institute. His research aims to enhance the timely detection of dementia, with a focus on developing strategies for primary and secondary prevention using machine learning. The Deep Dementia Phenotyping (DEMON) Network brings together academics, clinicians and other partners from across the world, and now it has joined forced with the UK Dementia Research Institute. The aim of this new collaboration is to rapidly speed up the transformation of data into clinical and biologically relevant knowledge in neurodegeneration research, to strengthen links with clinical researchers and industry, and to drive forward experimental dementia research using data science and artificial intelligence. There is no universally agreed definition of AI. The term broadly refers to computing technologies that resemble processes associated with human intelligence, such as reasoning, learning and adaptation, sensory understanding, and interaction. An important feature of contemporary AI technologies is that they are increasingly able to make sense of varied and unstructured kinds of data – so what could happen when you combine AI with large amounts of health and societal data? The potential is amazing, and could be the key to unlocking improved dementia risk analysis, diagnosis and treatments. You can find out more about our panellists, and their work on our website www.dementiaresearcher.nihr.ac.uk. A transcript of this podcast is also available here https://www.dementiaresearcher.nihr.ac.uk/podcast-gate-and-dementia Like what you hear? Please review, like, and share our podcast - and don't forget to subscribe to ensure you never miss an episode. _____________________________________________________________________ For more information on the collaboration visit: https://ukdri.ac.uk/news-and-events/new-partnership-with-the-demon-network-will-drive-forward-experimental-dementia-research To join the DEMON Network visit: http://demondementia.com/ _____________________________________________________________________ This podcast is brought to you in association with Alzheimer's Research UK and Alzheimer's Society, who we thank for their ongoing support.
Next Episode
Alzheimer's Society keeping research going during a pandemic
November 2, 2020
•43m
In this podcast Hannah Churchill, Research Communications Officer for Alzheimer’s Society takes the chair to talk with three Alzheimer’s Society funded researchers to discuss how they adapted in response to the pandemic. People with dementia have been worst hit by the COVID-19 pandemic – with over a quarter of people who died of COVID-19 between March and June 2020 having had dementia. Many dementia researchers have refocussed their work to study how the virus has impacted people living with dementia and their carers, to discover the likely long-term effects and to understand how care and support can be better provided in the future – ensuring lessons are learnt. Basic scientists turned their attention to COVID-19 testing, or took the time to learn new coding skills, write papers and to play the next stages of the research. While clinical researchers mostly returned to be entirely focussed on front line care within the NHS. The show is pleased to welcome: Dr Nuriye Kupeli, Senior Research Fellow from University College London. Nuriye, is works on understanding how compassion is experienced by family carers and developing interventions to support carers in their role. Dr Claire Pentecost, IDEAL Programme Manager from University of Exeter. IDEAL is the largest study of living well with dementia in the UK. The evidence will enable the development of new policy, interventions and initiatives to transform the lives of people with dementia and their carers. Remco Tuijt, PhD Student, University College London. Remco, is researching Post-diagnostic dementia care using interviews to explore healthcare experiences for people with dementia, their carers and their healthcare professionals. You can find out more about our panellists, and their work on our website: www.dementiaresearcher.nihr.ac.uk A transcript of this podcast is also available here https://www.dementiaresearcher.nihr.ac.uk/podcast-alzheimers-society-keeping-research-going-during-a-pandemic/ Like what you hear? Please review, like, and share our podcast - and don't forget to subscribe to ensure you never miss an episode. _____________________________________________________________________ The Alzheimer’s Society “Worst hit: Dementia during coronavirus” report can be found here: https://www.alzheimers.org.uk/sites/default/files/2020-09/Worst-hit-Dementia-during-coronavirus-report.pdf Information on Alzheimer’s Society research grants can be found here: https://www.alzheimers.org.uk/research/researchers/grants For information on the IDEAL Study visit: http://www.idealproject.org.uk/ _____________________________________________________________________ This podcast is brought to you in association with Alzheimer's Research UK and Alzheimer's Society, who we thank for their ongoing support.
If you like this episode you’ll love
Promoted